The latest news and articles
Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis
Here’s the English translation of that sentence:
**The oral capsule *Zeponim* (Ozanimod), developed by specialists at Alborz Zagros Pharmaceutical Company — a subsidiary of Actover Group — has been produced for the management of relapsing Multiple Sclerosis (MS) and Ulcerative Colitis (an inflammatory bowel disease).**
Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025
Tehran, July 2025 – At the sidelines of the 13th Iran Supplex,Iran’s leading exhibition and congress for dietary, nutritional, and sports supplements.
Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology
Tehran, May 2025 — Actover Pharmaceutical Group participated in the 32nd Iranian Congress of Neurology and Clinical Electrophysiology, presenting a wide range of its neurological products to healthcare professionals and field experts.
Labor Day Tribute from Actoverco
International Labor Day is a global tribute to the unwavering will and tireless hands that shape the future. It is a meaningful occasion to honor those whose dedication, expertise, and commitment drive the engines of progress and prosperity.
Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity
Eid al-Fitr, a celebration of devotion and righteousness, marks the dawn of divine mercy and the season of harvesting the vibrant fruits of answered prayers. Wishing all Muslims around the world a blessed Eid.
First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment
The first session of the AcTrip (Actoverco Thyroid Insight Practice) conference series, organized by Actoverco Pharmaceutical Group, was held with the aim of reviewing the challenges of screening, diagnosis, treatment, and follow-up of hypothyroidism (underactive thyroid). The event brought together 300 distinguished physicians and leading endocrinologists.
Pregnancy Awareness Promotion Week
February 3 to February 17 has been designated as “Pregnancy Awareness Promotion Week,” providing a great opportunity to once again emphasize the importance of increasing couples’ awareness of the dos and don’ts of pregnancy, enhancing maternal and fetal health, and preventing potential risks during pregnancy.
Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis
The 6th International Congress on Minimally Invasive Techniques in Gynecology, Obstetrics, and Endometriosis took place from January 23 to 25 at Abureihan Hall, Shahid Beheshti University, with Atipharmed, a subsidiary of Actoverco, as its key sponsor.
Conferences and Exhibitions
